Klaiber A
Psychiatric University Hospital, , ,
PreprintPsilocybin
Psychedelics distinctly alter brain entropy and complexity compared to psychostimulants
ArticlePsilocybin
The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic research.
ArticleMescaline
Pharmacokinetics, Pharmacodynamics, and Urinary Recovery of Oral Mescaline Hydrochloride in Healthy Participants.
ArticleLSD
Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults: A Randomized Clinical Trial.
ArticlePsilocybin
Motivation and retrospective appraisal of psychedelic study participation: a qualitative study in healthy volunteers.
ArticleDMT
Acute dose-dependent effects and self-guided titration of continuous N,N-dimethyltryptamine infusions in a double-blind placebo-controlled study in healthy participants.
ArticleMescaline
Safety pharmacology of acute mescaline administration in healthy participants.
ArticleMescaline
Acute dose-dependent effects of mescaline in a double-blind placebo-controlled study in healthy subjects.
ArticleMDMA
Acute effects of R-MDMA, S-MDMA, and racemic MDMA in a randomized double-blind cross-over trial in healthy participants.
ArticleMDMA
Acute effects of MDMA and LSD co-administration in a double-blind placebo-controlled study in healthy participants.
ArticlePsilocybin
Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants.
ArticleDMT
Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants.
ArticleLSD
Ketanserin Reverses the Acute Response to LSD in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Participants.
ArticleMescaline
Development and validation of an LC-MS/MS method for the quantification of mescaline and major metabolites in human plasma.
ArticlePsilocybin